Ozempic vs Wegovy: Same Molecule, Two FDA Labels

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The PlexusDx Education Hub unpacks GLP-1 therapies, weight-management protocols, and the genetic variables sitting behind each metabolic choice. Browse the Peptides & GLP-1 collection.

This is an independent editorial review. PlexusDx has no commercial arrangement with Novo Nordisk, which markets both products discussed here.

Ozempic and Wegovy generate a lot of confusion for a simple reason: they are the same molecule wearing two different labels. Semaglutide sits inside both. What separates them is the indication each was approved for and the dosing that indication carries, not the underlying pharmacology. This review reflects publicly available information as of April 2026.

One semaglutide molecule, two approved jobs

Ozempic and Wegovy are both selective GLP-1 receptor agonists marketed by Novo Nordisk, and both contain semaglutide. The mechanism is identical; the branding, the labeled indication, and the dosing schedule are what diverge. Understanding that distinction clears up most of the questions people bring to a side-by-side search.

Why the pharmacology is identical but the label is not

Because both drugs activate the same GLP-1 receptor across the pancreas, hypothalamus, and gut, they slow gastric emptying, temper post-meal glucose swings, and heighten satiety signaling in the same way. Regulators, however, approve products for specific uses, so the same active ingredient can appear under two names with two indications and two titration paths.

Diabetes indication versus weight-management indication

Ozempic received FDA approval for type 2 diabetes in 2017, and its active ingredient has been widely studied for weight management. Wegovy received FDA approval in 2021 for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. The indication shapes prescribing and insurance coverage.

What SUSTAIN and STEP each measured

Ozempic was evaluated in the SUSTAIN program for glycemic and cardiovascular outcomes, while Wegovy was evaluated in the STEP program for chronic weight management. Indirect comparisons exist across programs, and SURPASS compared tirzepatide against semaglutide 1 mg in type 2 diabetes, but populations and endpoints differ enough that per-trial reading beats broad claims.

A shared side-effect profile

Since the molecule is the same, the tolerability picture is largely shared. Gastrointestinal symptoms — nausea, vomiting, diarrhea, and constipation — are most common and usually most noticeable during dose escalation. Both carry the GLP-1 class boxed warning for thyroid C-cell tumor risk observed in rodent studies, and both list rare pancreatitis, gallbladder, and dehydration-related kidney events.

The price gap between two labels

At U.S. list price as of April 2026, Ozempic runs approximately $968–$1,029 per month and Wegovy approximately $1,349 per month (Novo Nordisk published pricing for both). The gap between two products built on one molecule underscores how much indication and packaging drive list price. Out-of-pocket cost still depends on coverage, savings cards, the prescribed indication, and compounded-pathway availability.

Genes that set your appetite baseline

The same molecule meets a different body in every person, and genetics is part of why. Variants in FTO, the fat-mass and obesity-associated gene, influence appetite regulation and adiposity set-point, while GLP1R, MC4R, and TCF7L2 shape receptor signaling, energy balance, and glucose handling. These pathway-level variants do not predict drug response but describe the terrain semaglutide acts on.

PlexusDx offers semaglutide through its Weight Management Protocols, including the Semaglutide protocol. The upstream genetic context is what sets the approach apart. Before any GLP-1 pathway protocol starts, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, MC4R, and TCF7L2 variants that shape your appetite-regulation and energy-balance biology. Pairing that profile with a protocol is the test before you invest approach.

Related reading on PlexusDx: Ozempic Uses, Novo Nordisk Ozempic, Ozempic Strength, Ozempic and Wegovy.

Disclaimer: This article is educational. PlexusDx offers semaglutide through its Weight Management Protocols, and this page covers the mechanism, evidence, and genetic context that inform any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Explore the Weight Management Protocols collection, or begin upstream with the Precision Peptide Genetic Test to read your GLP-1 pathway biology before committing.

Frequently Asked Questions about Ozempic and Wegovy

Are Ozempic and Wegovy the same drug?

They share the same active ingredient, semaglutide, and the same GLP-1 mechanism, so pharmacologically they are very close. They are not marketed as the same product, though: Ozempic is labeled for type 2 diabetes and Wegovy for chronic weight management, with different approved doses and titration schedules attached to each label.

Can I use Ozempic for weight loss instead of Wegovy?

That is a prescribing decision, not a self-serve substitution. Both contain semaglutide, but they are approved for different indications at different doses, and coverage often follows the labeled use. A clinician weighs your history, goals, and insurance before deciding which label and dose fit, rather than reading across from a comparison page.

Does genetics explain why semaglutide works differently for people?

Genetics is one contributing factor. Variants in FTO, MC4R, and TCF7L2 shape baseline appetite and energy balance, which is the terrain any GLP-1 compound acts on. The Precision Peptide Genetic Test maps those pathways but does not predict how you will respond to Ozempic, Wegovy, or any medication.

Why does Wegovy list higher than Ozempic?

List pricing reflects manufacturer and packaging decisions tied to each indication rather than a difference in the molecule itself. As of April 2026 Wegovy carries a higher published monthly figure than Ozempic, but what you pay depends on insurance, savings cards, the prescribed indication, and whether a compounded pathway applies.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.